Intelligence Platform

Patents

Browse 400 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7560437

Nucleic acid compositions for eliciting an immune response against telomerase reverse tran

The Regents of the University of Colorado · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553490

Vaccines against Escherichia coli O157 infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541043

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501494

Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatme

United Biomedical, Inc. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501132

Multiple antigenic peptides immunogenic against Streptococcus pneumonia

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452964

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7435801

Antibodies and other ligands directed against KIR2DL4 receptor for production of interfero

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410979

Synergistically effective combinations of dihaloacetamide compounds and interferon or riba

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410644

Recombinant pox virus for immunization against tumor-associated antigens

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407664

Peptide vaccines against group A streptococci

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7404961

Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family protei

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378093

Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus select

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7374931

Vaccine against staphylococcus intoxication

The United States of America as represented by the Secretary of the Army · Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7375074

Body weight gain inhibitor

Takeda Chemical Industries Ltd. · Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371821

Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be

United States of America as represented by the Secretary of the Air Force · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368116

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332469

Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects ag

The Board of Regents of the University of Texas System · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7268148

Compositions and methods for use against acne-induced inflammation and dermal matrix-degra

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7262027

Polypeptide and DNA immunization against Coccidioides spp. infections

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247307

Vaccines against Escherichia coli O157 infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7238800

Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp.

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7235644

Vaccine against Gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223844

Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus select

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted